Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography

Arthritis and Rheumatism

Volumn 63, Issue 7, 2011, Pages 1898-1907

  Piscaer, Tom M ^a   Müller, Cristina ^b   Mindt, Thomas L ^c   Lubberts, Erik ^a   Verhaar, Jan A N ^a   Krenning, Eric P ^a   Schibli, Roger ^b   De Jong, Marjon ^a   Weinans, Harrie ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ETH Zurich   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; DIETHYLENETRIAMINEPENTAACETIC ACID FOLATE; FOLATE RECEPTOR; INDIUM 111; IODOACETIC ACID; LIPOSOME; PENTETIC ACID DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; IMAGE ANALYSIS; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RADIOACTIVITY; RAT; RECEPTOR BLOCKING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; OSTEOARTHRITIS; RATS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79959858929     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30363     Document Type: Article

References (39)

1. Blom AB, Van Lent PL, Holthuysen AE, Van der Kraan PM, Roth J, Van Rooijen N, et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004; 12: 627-35. (Pubitemid 39022781)
2. Van Lent PL, Blom AB, Van der Kraan P, Holthuysen AE, Vitters E, Van Rooijen N, et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor β-mediated osteophyte formation. Arthritis Rheum 2004; 50: 103-11. (Pubitemid 38084294)
3. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE,. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006; 8: R187.
4. Lauder SN, Carty SM, Carpenter CE, Hill RJ, Talamas F, Bondeson J, et al. Interleukin-1β induced activation of nuclear factor-ÎB can be inhibited by novel pharmacological agents in osteoarthritis. Rheumatology (Oxford) 2007; 46: 752-8. (Pubitemid 47061703)
5. Blaney Davidson EN, Vitters EL, Mooren FM, Oliver N, Van den Berg WB, Van der Kraan PM,. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum 2006; 54: 1653-61.
6. Bakker AC, Van De Loo FA, Van Beuningen HM, Sime P, Van Lent PL, Van der Kraan PM, et al. Overexpression of active TGF-β1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 2001; 9: 128-36. (Pubitemid 32229262)
7. Blom AB, Van Lent PL, Libregts S, Holthuysen AE, Van der Kraan PM, Van Rooijen N, et al. Crucial role of macrophages in matrix metalloproteinase- mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007; 56: 147-57. (Pubitemid 46106187)
8. Haynes MK, Hume EL, Smith JB,. Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol 2002; 105: 315-25. (Pubitemid 36016059)
9. Sakkas LI, Johanson NA, Scanzello CR, Platsoucas CD,. Interleukin-12 is expressed by infiltrating macrophages and synovial lining cells in rheumatoid arthritis and osteoarthritis. Cell Immunol 1998; 188: 105-10. (Pubitemid 28493562)
10. Pelletier JP, Martel-Pelletier J, Abramson SB,. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [review]. Arthritis Rheum 2001; 44: 1237-47. (Pubitemid 32537520)
11. Turk MJ, Breur GJ, Widmer WR, Paulos CM, Xu LC, Grote LA, et al. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 2002; 46: 1947-55. (Pubitemid 34774528)
12. Low PS, Henne WA, Doorneweerd DD,. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008; 41: 120-9.
13. Van der Heijden JW, Oerlemans R, Dijkmans BA, Qi H, Van der Laken CJ, Lems WF, et al. Folate receptor β as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum 2009; 60: 12-21.
14. Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, Low PS,. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009; 113: 438-46.
15. 99mTc-radiofolate. J Nucl Med 2008; 49: 310-7. (Pubitemid 351225671)
16. 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med 2008; 49: 899-906. (Pubitemid 351793430)
17. Ke CY, Mathias CJ, Green MA,. Folate-receptor-targeted radionuclide imaging agents. Adv Drug Deliv Rev 2004; 56: 1143-60. (Pubitemid 38499700)
18. Sega EI, Low PS,. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev 2008; 27: 655-64.
19. 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nucl Med 2003; 44: 700-7. (Pubitemid 39655203)
20. Ostendorf B, Scherer A, Wirrwar A, Hoppin JW, Lackas C, Schramm NU, et al. High-resolution multipinhole single-photon-emission computed tomography in experimental and human arthritis. Arthritis Rheum 2006; 54: 1096-104. (Pubitemid 43672922)
21. Mindt TL, Muller C, Stuker F, Salazar JF, Hohn H, Mueggler T, et al. A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor. Bioconjug Chem 2009; 20: 1940-9.
22. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005; 114: 339-46. (Pubitemid 40385873)
23. Stoop R, Buma P, Van der Kraan PM, Hollander AP, Billinghurst RC, Meijers TH, et al. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis Cartilage 2001; 9: 308-15. (Pubitemid 32457789)
24. Santos L, Hall P, Metz C, Bucala R, Morand EF,. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001; 123: 309-14. (Pubitemid 32174784)
25. Van Rooijen N, Sanders A,. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174: 83-93.
26. Van Lent PL, Van den Bersselaar L, Van den Hoek AE, Van De Ende M, Dijkstra CD, Van Rooijen N, et al. Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate. Rheumatol Int 1993; 13: 21-30. (Pubitemid 23188944)
27. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K,. Mono-iodoacetate- induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003; 31: 619-24. (Pubitemid 37433471)
28. Piscaer TM, Waarsing JH, Kops N, Pavljasevic P, Verhaar JA, Van Osch GJ, et al. In vivo imaging of cartilage degeneration using microCT-arthrography. Osteoarthritis Cartilage 2008; 16: 1011-7.
29. Benito MJ, Veale DJ, FitzGerald O, Van den Berg WB, Bresnihan B,. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005; 64: 1263-7. (Pubitemid 41206240)
30. Farahat MN, Yanni G, Poston R, Panayi GS,. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993; 52: 870-5. (Pubitemid 24019143)
31. Paulos CM, Turk MJ, Breur GJ, Low PS,. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 2004; 56: 1205-17. (Pubitemid 38496516)
32. Leamon CP, Jackman AL,. Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam Horm 2008; 79: 203-33.
33. Nagayoshi R, Nagai T, Matsushita K, Sato K, Sunahara N, Matsuda T, et al. Effectiveness of anti-folate receptor β antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages. Arthritis Rheum 2005; 52: 2666-75. (Pubitemid 41369094)
34. Nakashima-Matsushita N, Homma T, Yu S, Matsuda T, Sunahara N, Nakamura T, et al. Selective expression of folate receptor β and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 1609-16. (Pubitemid 30263627)
35. Matteson EL, Lowe VJ, Prendergast FG, Crowson CS, Moder KG, Morgenstern DE, et al. Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol 2009; 27: 253-9.
36. Thorek DL, Chen AK, Czupryna J, Tsourkas A,. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006; 34: 23-38.
37. 99mTc-labelled J001 for scintigraphic assessment of experimental osteoarthritis in the rabbit. Br J Rheumatol 1997; 36: 758-62.
38. Akira S, Takeda K, Kaisho T,. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-80. (Pubitemid 32747155)
39. Blom AB, Brockbank SM, Van Lent PL, Van Beuningen HM, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009; 60: 501-12.